Logo image of NOV

NOV INC (NOV) Stock Fundamental Analysis

NYSE:NOV - US62955J1034 - Common Stock

12.87 USD
-0.29 (-2.2%)
Last: 8/26/2025, 8:04:01 PM
13.12 USD
+0.25 (+1.94%)
After Hours: 8/26/2025, 8:04:01 PM
Fundamental Rating

5

Overall NOV gets a fundamental rating of 5 out of 10. We evaluated NOV against 61 industry peers in the Energy Equipment & Services industry. Both the profitability and the financial health of NOV get a neutral evaluation. Nothing too spectacular is happening here. NOV has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NOV was profitable.
NOV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NOV reported negative net income in multiple years.
NOV had a positive operating cash flow in 4 of the past 5 years.
NOV Yearly Net Income VS EBIT VS OCF VS FCFNOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B

1.2 Ratios

NOV has a Return On Assets (4.15%) which is comparable to the rest of the industry.
NOV has a Return On Equity of 7.24%. This is comparable to the rest of the industry: NOV outperforms 52.46% of its industry peers.
With a Return On Invested Capital value of 6.10%, NOV perfoms like the industry average, outperforming 52.46% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NOV is below the industry average of 8.01%.
The last Return On Invested Capital (6.10%) for NOV is above the 3 year average (5.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.15%
ROE 7.24%
ROIC 6.1%
ROA(3y)5.3%
ROA(5y)-2.46%
ROE(3y)9.7%
ROE(5y)-4.94%
ROIC(3y)5.23%
ROIC(5y)N/A
NOV Yearly ROA, ROE, ROICNOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

NOV has a Profit Margin (5.36%) which is comparable to the rest of the industry.
NOV has a Operating Margin of 8.28%. This is comparable to the rest of the industry: NOV outperforms 44.26% of its industry peers.
NOV has a worse Gross Margin (21.37%) than 65.57% of its industry peers.
In the last couple of years the Gross Margin of NOV has grown nicely.
Industry RankSector Rank
OM 8.28%
PM (TTM) 5.36%
GM 21.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.38%
GM growth 5Y17.86%
NOV Yearly Profit, Operating, Gross MarginsNOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NOV is destroying value.
The number of shares outstanding for NOV has been reduced compared to 1 year ago.
The number of shares outstanding for NOV has been reduced compared to 5 years ago.
Compared to 1 year ago, NOV has a worse debt to assets ratio.
NOV Yearly Shares OutstandingNOV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NOV Yearly Total Debt VS Total AssetsNOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

NOV has an Altman-Z score of 1.89. This is not the best score and indicates that NOV is in the grey zone with still only limited risk for bankruptcy at the moment.
NOV has a Altman-Z score (1.89) which is in line with its industry peers.
The Debt to FCF ratio of NOV is 2.20, which is a good value as it means it would take NOV, 2.20 years of fcf income to pay off all of its debts.
NOV's Debt to FCF ratio of 2.20 is fine compared to the rest of the industry. NOV outperforms 72.13% of its industry peers.
NOV has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.30, NOV is doing good in the industry, outperforming 62.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.2
Altman-Z 1.89
ROIC/WACC0.72
WACC8.42%
NOV Yearly LT Debt VS Equity VS FCFNOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

NOV has a Current Ratio of 2.58. This indicates that NOV is financially healthy and has no problem in meeting its short term obligations.
NOV's Current ratio of 2.58 is fine compared to the rest of the industry. NOV outperforms 78.69% of its industry peers.
A Quick Ratio of 1.72 indicates that NOV should not have too much problems paying its short term obligations.
The Quick ratio of NOV (1.72) is better than 65.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.72
NOV Yearly Current Assets VS Current LiabilitesNOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

NOV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.28%.
Measured over the past years, NOV shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.89% on average per year.
NOV shows a decrease in Revenue. In the last year, the revenue decreased by -1.22%.
The Revenue has been growing slightly by 0.91% on average over the past years.
EPS 1Y (TTM)-15.28%
EPS 3YN/A
EPS 5Y40.89%
EPS Q2Q%-49.12%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y17.1%
Revenue growth 5Y0.91%
Sales Q2Q%-1.26%

3.2 Future

Based on estimates for the next years, NOV will show a very negative growth in Earnings Per Share. The EPS will decrease by -12.45% on average per year.
Based on estimates for the next years, NOV will show a small growth in Revenue. The Revenue will grow by 1.67% on average per year.
EPS Next Y-34.11%
EPS Next 2Y-14.82%
EPS Next 3Y-5.61%
EPS Next 5Y-12.45%
Revenue Next Year-2.53%
Revenue Next 2Y-1.1%
Revenue Next 3Y-0.08%
Revenue Next 5Y1.67%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NOV Yearly Revenue VS EstimatesNOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
NOV Yearly EPS VS EstimatesNOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.55, which indicates a very decent valuation of NOV.
85.25% of the companies in the same industry are more expensive than NOV, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.08. NOV is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 11.02 indicates a reasonable valuation of NOV.
Based on the Price/Forward Earnings ratio, NOV is valued cheaper than 80.33% of the companies in the same industry.
NOV is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.55
Fwd PE 11.02
NOV Price Earnings VS Forward Price EarningsNOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

NOV's Enterprise Value to EBITDA is on the same level as the industry average.
90.16% of the companies in the same industry are more expensive than NOV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.26
EV/EBITDA 5.39
NOV Per share dataNOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as NOV's earnings are expected to decrease with -5.61% in the coming years.
PEG (NY)N/A
PEG (5Y)0.26
EPS Next 2Y-14.82%
EPS Next 3Y-5.61%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.42%, NOV has a reasonable but not impressive dividend return.
NOV's Dividend Yield is a higher than the industry average which is at 3.44.
Compared to an average S&P500 Dividend Yield of 2.34, NOV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

On average, the dividend of NOV grows each year by 6.81%, which is quite nice.
NOV has been paying a dividend for at least 10 years, so it has a reliable track record.
As NOV did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)6.81%
Div Incr Years2
Div Non Decr Years5
NOV Yearly Dividends per shareNOV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

40.98% of the earnings are spent on dividend by NOV. This is a bit on the high side, but may be sustainable.
DP40.98%
EPS Next 2Y-14.82%
EPS Next 3Y-5.61%
NOV Yearly Income VS Free CF VS DividendNOV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B
NOV Dividend Payout.NOV Dividend Payout, showing the Payout Ratio.NOV Dividend Payout.PayoutRetained Earnings

NOV INC

NYSE:NOV (8/26/2025, 8:04:01 PM)

After market: 13.12 +0.25 (+1.94%)

12.87

-0.29 (-2.2%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners105.54%
Inst Owner Change-0.37%
Ins Owners0.74%
Ins Owner Change4.16%
Market Cap4.78B
Analysts71.54
Price Target15.84 (23.08%)
Short Float %6.57%
Short Ratio5.84
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend0.28
Dividend Growth(5Y)6.81%
DP40.98%
Div Incr Years2
Div Non Decr Years5
Ex-Date09-12 2025-09-12 (0.075)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.07%
Min EPS beat(2)-25.76%
Max EPS beat(2)-2.37%
EPS beat(4)1
Avg EPS beat(4)-6.99%
Min EPS beat(4)-25.76%
Max EPS beat(4)10.12%
EPS beat(8)3
Avg EPS beat(8)-0.61%
EPS beat(12)6
Avg EPS beat(12)2.21%
EPS beat(16)8
Avg EPS beat(16)23.64%
Revenue beat(2)1
Avg Revenue beat(2)0.11%
Min Revenue beat(2)-0.85%
Max Revenue beat(2)1.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)1.94%
Revenue beat(8)6
Avg Revenue beat(8)0.61%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)11
Avg Revenue beat(16)0.8%
PT rev (1m)-2.96%
PT rev (3m)-5.62%
EPS NQ rev (1m)-13.49%
EPS NQ rev (3m)-29.59%
EPS NY rev (1m)-9.36%
EPS NY rev (3m)-11.57%
Revenue NQ rev (1m)0.84%
Revenue NQ rev (3m)-3.57%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 10.55
Fwd PE 11.02
P/S 0.54
P/FCF 5.26
P/OCF 3.75
P/B 0.73
P/tB 1.09
EV/EBITDA 5.39
EPS(TTM)1.22
EY9.48%
EPS(NY)1.17
Fwd EY9.08%
FCF(TTM)2.45
FCFY19.02%
OCF(TTM)3.44
OCFY26.7%
SpS23.67
BVpS17.51
TBVpS11.81
PEG (NY)N/A
PEG (5Y)0.26
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 7.24%
ROCE 7.98%
ROIC 6.1%
ROICexc 6.92%
ROICexgc 9.39%
OM 8.28%
PM (TTM) 5.36%
GM 21.37%
FCFM 10.34%
ROA(3y)5.3%
ROA(5y)-2.46%
ROE(3y)9.7%
ROE(5y)-4.94%
ROIC(3y)5.23%
ROIC(5y)N/A
ROICexc(3y)5.95%
ROICexc(5y)N/A
ROICexgc(3y)8.17%
ROICexgc(5y)N/A
ROCE(3y)6.84%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.38%
GM growth 5Y17.86%
F-Score5
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.2
Debt/EBITDA 1.79
Cap/Depr 104.86%
Cap/Sales 4.18%
Interest Coverage 8.77
Cash Conversion 118.37%
Profit Quality 192.99%
Current Ratio 2.58
Quick Ratio 1.72
Altman-Z 1.89
F-Score5
WACC8.42%
ROIC/WACC0.72
Cap/Depr(3y)89.05%
Cap/Depr(5y)79.41%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.28%
EPS 3YN/A
EPS 5Y40.89%
EPS Q2Q%-49.12%
EPS Next Y-34.11%
EPS Next 2Y-14.82%
EPS Next 3Y-5.61%
EPS Next 5Y-12.45%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y17.1%
Revenue growth 5Y0.91%
Sales Q2Q%-1.26%
Revenue Next Year-2.53%
Revenue Next 2Y-1.1%
Revenue Next 3Y-0.08%
Revenue Next 5Y1.67%
EBIT growth 1Y-11.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.02%
EBIT Next 3Y9.16%
EBIT Next 5Y6.84%
FCF growth 1Y287.04%
FCF growth 3Y119.59%
FCF growth 5Y14.65%
OCF growth 1Y659.65%
OCF growth 3Y64.86%
OCF growth 5Y12.8%